Personal Capital Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-3,337
Closed -$374K 553
2021
Q3
$374K Buy
+3,337
New +$374K ﹤0.01% 359